Clinical Trials Browser

Phase 2 × Castleman Disease × Rituximab × Clear all

NCT00127569 2007-01-12

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

Phase 2 Terminated

LymphoidSarcoma

Castleman Disease, Sarcoma, Kaposi, HIV Infections